Latest Partnerships News

Vitura Health has inked a binding distribution agreement with MedReleaf Australia, unlocking access to a broad medicinal cannabis portfolio across its extensive pharmacy network. This deal could add up to AUD 15 million annually, positioning Vitura as a dominant player in the evolving Australian market.

Argenica Therapeutics has secured a nearly $4 million R&D tax incentive rebate for FY25, strengthening its cash position as it prepares for a pivotal Phase 2b trial of its neuroprotective peptide ARG-007.

West Coast Silver Limited has launched a comprehensive geophysical survey campaign at its Elizabeth Hill silver project, aiming to uncover new high-grade mineralisation extensions and refine exploration targeting.

InteliCare Holdings has appointed seasoned healthcare executive Angus Cameron as CEO to lead its transition from pilot projects to full-scale commercial deployment following a major aged care contract.

Helix Resources has formalised a joint venture to earn up to 40% of the Gold Basin oxide gold project in Arizona, marking a significant expansion into a prolific US gold district. The agreement sets clear milestones for exploration and resource updates over the next two years.

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

Klevo Rewards’ subsidiary Fly Wallet has secured approval to join the SWIFT network, marking a key step in expanding its digital payments and rewards platform across the Asia-Pacific region.

Renascor Resources has completed construction of its Purified Spherical Graphite demonstration facility in Adelaide, marking a pivotal step towards commercialising its innovative HF-free purification process for battery anode materials.

Centaurus Metals has locked in a binding five-year offtake agreement with global giant Glencore for a third of its Jaguar Nickel Project’s output, marking a pivotal step towards commercial production in Brazil.

EcoGraf Limited has signed a non-binding MoU with Taiwan’s Long Time Technology to develop HFfree® purification facilities and expand battery anode operations across South East Asia and Taiwan, aiming to tap into Tier-1 OEM supply chains.

Racura Oncology has secured governance approval to launch its Phase 1 HARNESS-1 trial, testing RC220 alongside osimertinib in EGFR-mutated non-small cell lung cancer patients. This milestone sets the stage for a potentially pivotal new approach to overcoming resistance in lung cancer treatment.

ABx Group has announced a breakthrough with its second mixed rare earth carbonate sample from Tasmania’s Deep Leads deposit, boasting higher heavy rare earth content and fewer impurities. This advancement enhances project flexibility and strengthens ABx’s position in the competitive rare earths market.